Aligos Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aligos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aligos Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aligos Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $662 | 677 | 0.98 |
| 2023-12-31 | $450 | 677 | 0.66 |
| 2023-09-30 | $505 | 677 | 0.75 |
| 2023-06-30 | $657 | 677 | 0.97 |
| 2023-03-31 | $999 | 677 | 1.48 |
| 2022-12-31 | $999 | 677 | 1.48 |
| 2022-06-30 | $2.0k | 1.6k | 1.27 |
| 2022-03-31 | $31k | 15k | 2.12 |
| 2021-12-31 | $173k | 14k | 12.04 |
| 2021-03-31 | $675k | 30k | 22.87 |
| 2020-12-31 | $1.1M | 40k | 27.74 |